Evidence map›Paper›PMID 36119746›Full record

ArticleFrontiers in cardiovascular medicine2022

Development and validation of a machine learned algorithm to IDENTIFY functionally significant coronary artery disease.

Thomas Stuckey, Frederick Meine, Thomas McMinn, Jeremiah P Depta, Brett Bennett, Thomas McGarry, William Carroll, David Suh, John A Steuter, Michael Roberts and 8 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03864081 (Non-Invasive Point-of-care Diagnosis Using Machine Learning and Signal Analytics to Transform Early Detection of Heart Disease), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03864081 naunknown statusnot on this map

Non-Invasive Point-of-care Diagnosis Using Machine Learning and Signal Analytics to Transform Early Detection of Heart Disease

TypeinterventionalSponsorAnalytics For LifeRan2018 to 2022Enrolled2,500ConditionsCoronary Artery DiseaseArmsPhase Signal Recorder
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 1 country.

Thomas StuckeyCone Health Heart and Vascular Center, Greensboro, NC, United States.
Frederick MeineNovant Health New Hanover Regional Medical Center, Wilmington, NC, United States.
Thomas McMinnAustin Heart, Austin, TX, United States.
Jeremiah P DeptaRochester General Hospital, Rochester, NY, United States.
Brett BennettJackson Heart Clinic, Jackson, MS, United States.
Thomas McGarryOklahoma Heart Hospital, Oklahoma City, OK, United States.
William CarrollCardiology Associates of North Mississippi, Tupelo, MS, United States.
David SuhAtlanta Heart Specialists, Atlanta, GA, United States.
John A SteuterBryan Heart, Lincoln, NE, United States.
Michael RobertsLexington Medical Center, West Columbia, SC, United States.
Horace R GillinsCorVista Health, Inc., Washington, DC, United States.
Emmanuel LangeCorVista Health, Inc., Analytics For Life Inc., d.b.a CorVista Health, Toronto, ON, Canada.
Farhad FathiehCorVista Health, Inc., Analytics For Life Inc., d.b.a CorVista Health, Toronto, ON, Canada.
Timothy BurtonCorVista Health, Inc., Analytics For Life Inc., d.b.a CorVista Health, Toronto, ON, Canada.
Ali KhosousiCorVista Health, Inc., Analytics For Life Inc., d.b.a CorVista Health, Toronto, ON, Canada.
Ian ShadforthCorVista Health, Inc., Washington, DC, United States.
William E SandersCorVista Health, Inc., Washington, DC, United States.
Mark G RabbatLoyola University Medical Center, Maywood, IL, United States.
Bryan Health · USCone Health · USJackson Memorial Hospital · USLexington Medical Center · USLoyola University Medical Center · USNew Hanover Regional Medical Center · USNorth Mississippi Medical Center · USOklahoma Heart Hospital · USRochester General Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Multiple trials have demonstrated broad performance ranges for tests attempting to detect coronary artery disease. The most common test, SPECT, requires capital-intensive equipment, the use of radionuclides, induction of stress, and time off work and/or travel. Presented here are the development and clinical validation of an office-based machine learned algorithm to identify functionally significant coronary artery disease without radiation, expensive equipment or induced patient stress. Materials and methods: The IDENTIFY trial (NCT03864081) is a prospective, multicenter, non-randomized, selectively blinded, repository study to collect acquired signals paired with subject meta-data, including outcomes, from subjects with symptoms of coronary artery disease. Time synchronized orthogonal voltage gradient and photoplethysmographic signals were collected for 230 seconds from recumbent subjects at rest within seven days of either left heart catheterization or coronary computed tomography angiography. Following machine learning on a proportion of these data ( Results: At the pre-specified cut point, the sensitivity for detecting functionally significant coronary artery disease was 0.73 (95% CI: 0.68-0.78), and the specificity was 0.68 (0.62-0.74). There exists a point on the receiver operating characteristic curve at which the negative predictive value is the same as coronary computed tomographic angiography, 0.99, assuming a disease incidence of 0.04, yielding sensitivity of 0.89 and specificity of 0.42. Selecting a point at which the positive predictive value is maximized, 0.12, yields sensitivity of 0.39 and specificity of 0.88. Conclusion: The performance of the machine learned algorithm presented here is comparable to common tertiary center testing for coronary artery disease. Employing multiple cut points on the receiver operating characteristic curve can yield the negative predictive value of coronary computed tomographic angiography and a positive predictive value approaching that of myocardial perfusion imaging. As such, a system employing this algorithm may address the need for a non-invasive, no radiation, no stress, front line test, and hence offer significant advantages to the patient, their physician, and healthcare system.

Indexed as

artificial intelligencecoronary artery diseasedigital healthfront line testingmachine learning (ML)

Identifiers

PMID36119746
PMCPMC9481304
OpenAlexW4294243340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.